{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:45:18Z","timestamp":1790178318321,"version":"4.1.0"},"reference-count":73,"publisher":"Oxford University Press (OUP)","issue":"suppl_1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5,1]]},"DOI":"10.1093\/asj\/sjw284","type":"journal-article","created":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T14:15:13Z","timestamp":1491574513000},"page":"S4-S11","source":"Crossref","is-referenced-by-count":57,"title":["AbobotulinumtoxinA: A 25-Year History"],"prefix":"10.1093","volume":"37","author":[{"given":"Gary D.","family":"Monheit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Pickett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,4,7]]},"reference":[{"issue":"12","key":"key\n\t\t\t\t20170407101028_CIT0001","first-page":"924","article-title":"Pharmacologic weakening of extraocular muscles","volume":"12","year":"1973","journal-title":"Invest Ophthalmol"},{"issue":"2","key":"key\n\t\t\t\t20170407101028_CIT0002","first-page":"5886","article-title":"Botulinum neurotoxin type A in neurology: update","volume":"7","year":"2015","journal-title":"Neurol Int"},{"issue":"10","key":"key\n\t\t\t\t20170407101028_CIT0003","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3390\/toxins4100913","article-title":"Clinical uses of botulinum neurotoxins: current indications, limitations and future developments","volume":"4","year":"2012","journal-title":"Toxins (Basel)"},{"issue":"4","key":"key\n\t\t\t\t20170407101028_CIT0004","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1468-3083.2007.02457.x","article-title":"Botulinum toxin type-A for the treatment of inverse psoriasis","volume":"22","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"11","key":"key\n\t\t\t\t20170407101028_CIT0005","first-page":"1407","article-title":"Efficacy of botulinum neurotoxin type A for treating recalcitrant plaque psoriasis","volume":"13","year":"2014","journal-title":"J Drugs Dermatol"},{"issue":"5","key":"key\n\t\t\t\t20170407101028_CIT0006","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1001\/archdermatol.2011.111","article-title":"Inverse psoriasis and hyperhidrosis of the axillae responding to botulinum toxin type A","volume":"147","year":"2011","journal-title":"Arch Dermatol"},{"issue":"5","key":"key\n\t\t\t\t20170407101028_CIT0007","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/asj\/sju150","article-title":"Sebum production alteration after botulinum toxin type A injections for the treatment of forehead rhytides: a prospective randomized double-blind dose-comparative clinical investigation","volume":"35","year":"2015","journal-title":"Aesthet Surg J"},{"issue":"9","key":"key\n\t\t\t\t20170407101028_CIT0008","first-page":"847","article-title":"Use of intradermal botulinum toxin to reduce sebum production and facial pore size","volume":"7","year":"2008","journal-title":"J Drugs Dermatol"},{"issue":"5","key":"key\n\t\t\t\t20170407101028_CIT0009","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1177\/0363546516629432","article-title":"The use of sonographically guided botulinum toxin type A (Dysport) injections into the tensor fasciae latae for the treatment of lateral patellofemoral overload syndrome","volume":"44","year":"2016","journal-title":"Am J Sports Med"},{"issue":"1","key":"key\n\t\t\t\t20170407101028_CIT0010","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.det.2013.09.009","article-title":"Aesthetic uses of the botulinum toxin","volume":"32","year":"2014","journal-title":"Dermatol Clin"},{"key":"key\n\t\t\t\t20170407101028_CIT0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/asj\/36.Supplement_1.1","article-title":"Cosmetic Surgery National Data Bank Statistics","volume":"36","year":"2016","journal-title":"Aesthet Surg J"},{"issue":"4","key":"key\n\t\t\t\t20170407101028_CIT0012","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00702-007-0728-2","article-title":"From poison to remedy: the chequered history of botulinum toxin","volume":"115","year":"2008","journal-title":"J Neural Transm (Vienna)"},{"issue":"3","key":"key\n\t\t\t\t20170407101028_CIT0013","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/jnnp.58.3.283","article-title":"Atropa belladonna (deadly nightshade)","volume":"58","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"key\n\t\t\t\t20170407101028_CIT0014","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1212\/WNL.53.8.1850","article-title":"Historical aspects of botulinum toxin: Justinus Kerner (1786-1862) and the \u201csausage poison\u201d","volume":"53","year":"1999","journal-title":"Neurology"},{"issue":"3","key":"key\n\t\t\t\t20170407101028_CIT0015","doi-asserted-by":"crossref","first-page":"258","DOI":"10.7861\/clinmedicine.4-3-258","article-title":"The story of Clostridium botulinum: from food poisoning to Botox","volume":"4","year":"2004","journal-title":"Clin Med (Lond)"},{"key":"key\n\t\t\t\t20170407101028_CIT0016","volume-title":"Travel shadows: translated from the German and edited by Harold B Segel","year":"2014"},{"key":"key\n\t\t\t\t20170407101028_CIT0017"},{"issue":"3","key":"key\n\t\t\t\t20170407101028_CIT0018","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.mib.2012.05.005","article-title":"Learning from the past: historical aspects of bacterial toxins as pharmaceuticals","volume":"15","year":"2012","journal-title":"Curr Opin Microbiol"},{"key":"key\n\t\t\t\t20170407101028_CIT0019","first-page":"231","article-title":"Untersuchungen \u00fcber Bakteriengifte, Berlin","volume":"27","year":"1890","journal-title":"Klin Wochenschr"},{"issue":"5","key":"key\n\t\t\t\t20170407101028_CIT0020","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1128\/JB.2.5.505-566.1917","article-title":"The families and genera of the bacteria: preliminary report of the committee of the society of American bacteriologists on characterization and classification of bacterial types","volume":"2","year":"1917","journal-title":"J Bacteriol"},{"key":"key\n\t\t\t\t20170407101028_CIT0021","volume-title":"Studies on organisms concerned as causative factors in botulism. Hygiene Laboratory Bulletin 136","year":"1924"},{"issue":"6","key":"key\n\t\t\t\t20170407101028_CIT0022","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1001\/archpedi.1979.02130060020002","article-title":"Infant botulism in 1931. Discovery of a misclassified case","volume":"133","year":"1979","journal-title":"Am J Dis Child"},{"key":"key\n\t\t\t\t20170407101028_CIT0023","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1128\/JB.50.2.213-217.1945","article-title":"The occurrence of Bacillus botulinus, types A and B, in accidental wounds","volume":"50","year":"1945","journal-title":"J Bacteriol"},{"issue":"1","key":"key\n\t\t\t\t20170407101028_CIT0024","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF02284114","article-title":"Beitr\u00e4ge zur Kenntnis des Toxins und antitoxins des Bacillus botulinus","volume":"65","year":"1910","journal-title":"Z Hyg Infektionskr"},{"issue":"5","key":"key\n\t\t\t\t20170407101028_CIT0025","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1128\/JB.4.5.555-570.1.1919","article-title":"Notes on Bacillus botulinus","volume":"4","year":"1919","journal-title":"J Bacteriol"},{"issue":"1","key":"key\n\t\t\t\t20170407101028_CIT0026","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1046\/j.1365-2672.1997.00313.x","article-title":"Phylogeny and taxonomy of the food-borne pathogen Clostridium botulinum and its neurotoxins","volume":"84","year":"1998","journal-title":"J Appl Microbiol"},{"issue":"8","key":"key\n\t\t\t\t20170407101028_CIT0027","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrmicro3295","article-title":"Botulinum neurotoxins: genetic, structural and mechanistic insights","volume":"12","year":"2014","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"key\n\t\t\t\t20170407101028_CIT0028","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.clinph.2012.11.004","article-title":"Botulinum neurotoxin serotype D is poorly effective in humans: an in vivo electrophysiological study","volume":"124","year":"2013","journal-title":"Clin Neurophysiol"},{"issue":"5","key":"key\n\t\t\t\t20170407101028_CIT0029","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/infdis\/39.5.345","article-title":"The purification of botulinum toxin","volume":"39","year":"1926","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170407101028_CIT0030","first-page":"734","article-title":"Botulinum toxin injection of eye muscles to correct strabismus","volume":"79","year":"1981","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"6","key":"key\n\t\t\t\t20170407101028_CIT0031","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1136\/bjo.47.6.383","article-title":"Conrad Berens, 1889\u20131963","volume":"47","year":"1963","journal-title":"Br J Ophthalmol"},{"issue":"3\/4","key":"key\n\t\t\t\t20170407101028_CIT0032","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1504\/TBJ.2013.055664","article-title":"Historical aspects of botulinum toxin used clinically: part I: is that the right serotype?","volume":"2","year":"2013","journal-title":"Botulinum J"},{"issue":"1","key":"key\n\t\t\t\t20170407101028_CIT0033","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1128\/MMBR.56.1.80-99.1992","article-title":"Properties and use of botulinum toxin and other microbial neurotoxins in medicine","volume":"56","year":"1992","journal-title":"Microbiol Rev"},{"issue":"10","key":"key\n\t\t\t\t20170407101028_CIT0034","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S0161-6420(80)35127-0","article-title":"Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery","volume":"87","year":"1980","journal-title":"Ophthalmology"},{"key":"key\n\t\t\t\t20170407101028_CIT0035","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/0065955X.1985.11981659","article-title":"Botulinum toxin treatment of strabismus","volume":"35","year":"1985","journal-title":"Am Orthopt J"},{"issue":"6","key":"key\n\t\t\t\t20170407101028_CIT0036","first-page":"785","article-title":"Neurologic uses of botulinum neurotoxin type A","volume":"3","year":"2007","journal-title":"Neuropsychiatr Dis Treat"},{"key":"key\n\t\t\t\t20170407101028_CIT0037"},{"key":"key\n\t\t\t\t20170407101028_CIT0038"},{"issue":"10","key":"key\n\t\t\t\t20170407101028_CIT0039","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1136\/bjo.69.10.718","article-title":"Treatment of strabismus in adults with botulinum toxin A","volume":"69","year":"1985","journal-title":"Br J Ophthalmol"},{"key":"key\n\t\t\t\t20170407101028_CIT0040","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/B978-0-12-447180-1.50024-9","article-title":"Production, purification and toxoiding of Clostridium Botulinum type a toxin A2","volume-title":"Biomedical Aspects of Botulism","year":"1981"},{"issue":"7","key":"key\n\t\t\t\t20170407101028_CIT0041","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/mus.880180708","article-title":"Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin","volume":"18","year":"1995","journal-title":"Muscle Nerve"},{"issue":"1","key":"key\n\t\t\t\t20170407101028_CIT0042","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/jnnp.64.1.13","article-title":"What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport. German Dystonia Study Group","volume":"64","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"key\n\t\t\t\t20170407101028_CIT0043","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/jnnp.64.1.6","article-title":"A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia","volume":"64","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"key\n\t\t\t\t20170407101028_CIT0044","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jaad.2003.11.084","article-title":"A multicenter, randomized, double-blind, placebo-controlled study of efficacy and safety of 3 doses of botulinum toxin A in the treatment of glabellar lines","volume":"51","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"key\n\t\t\t\t20170407101028_CIT0045","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1067\/mjd.2002.121356","article-title":"A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines","volume":"46","author":"BOTOX Glabellar Lines I Study Group","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"key\n\t\t\t\t20170407101028_CIT0046","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1097\/DSS.0000000000000531","article-title":"A randomized, double-blind trial to investigate the equivalence of IncobotulinumtoxinA and OnabotulinumtoxinA for glabellar frown lines","volume":"41","year":"2015","journal-title":"Dermatol Surg"},{"issue":"1","key":"key\n\t\t\t\t20170407101028_CIT0047","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/1090820X11430685","article-title":"Prospective randomized comparison of onabotulinumtoxinA (Botox) and abobotulinumtoxinA (Dysport) in the treatment of forehead, glabellar, and periorbital wrinkles","volume":"32","year":"2012","journal-title":"Aesthet Surg J"},{"issue":"11","key":"key\n\t\t\t\t20170407101028_CIT0048","first-page":"1447","article-title":"A randomized double-blind study of the effect of Botox and Dysport\/Reloxin on forehead wrinkles and electromyographic activity","volume":"143","year":"2007","journal-title":"Arch Dermatol"},{"issue":"11","key":"key\n\t\t\t\t20170407101028_CIT0049","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/j.1524-4725.1998.tb04092.x","article-title":"History of the cosmetic use of Botulinum A exotoxin","volume":"24","year":"1998","journal-title":"Dermatol Surg"},{"issue":"9","key":"key\n\t\t\t\t20170407101028_CIT0050","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1001\/archotol.1993.01880210108015","article-title":"Botulinum toxin for the treatment of hyperfunctional lines of the face","volume":"119","year":"1993","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"2","key":"key\n\t\t\t\t20170407101028_CIT0051","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00006534-198908000-00027","article-title":"Botulinum toxin: a treatment for facial asymmetry caused by facial nerve paralysis","volume":"84","year":"1989","journal-title":"Plast Reconstr Surg"},{"issue":"2","key":"key\n\t\t\t\t20170407101028_CIT0052","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/01.PRS.0000150149.74749.55","article-title":"Botulinum toxin: a treatment for facial asymmetry caused by facial nerve paralysis","volume":"115","year":"2005","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"key\n\t\t\t\t20170407101028_CIT0053","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1524-4725.1992.tb03295.x","article-title":"Treatment of glabellar frown lines with C. botulinum-A exotoxin","volume":"18","year":"1992","journal-title":"J Dermatol Surg Oncol"},{"issue":"11","key":"key\n\t\t\t\t20170407101028_CIT0054","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/j.1524-4725.1998.tb04095.x","article-title":"Botulinum A toxin for glabellar wrinkles. Dose and response","volume":"24","year":"1998","journal-title":"Dermatol Surg"},{"key":"key\n\t\t\t\t20170407101028_CIT0055","first-page":"101","article-title":"Pilot study to compare the efficacy and the duration of activity of Dysport vs Botox in classical esthetic indications (forehead, glabella, crow\u2019s feet)","volume":"30","year":"2003","journal-title":"Le Journal de M\u00e9decine Esth\u00e9tique et de Chirurgie Dermatologique"},{"issue":"3","key":"key\n\t\t\t\t20170407101028_CIT0056","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1001\/archderm.142.3.320","article-title":"Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region","volume":"142","year":"2006","journal-title":"Arch Dermatol"},{"issue":"2","key":"key\n\t\t\t\t20170407101028_CIT0057","first-page":"92","article-title":"Anaphylaxis after vaccination due to hypersensitivity to gelatin","volume":"218","year":"2006","journal-title":"Klin Padiatr"},{"issue":"5","key":"key\n\t\t\t\t20170407101028_CIT0058","doi-asserted-by":"crossref","first-page":"NP102","DOI":"10.1093\/asj\/sju105","article-title":"Report of allergic reaction after application of botulinum toxin","volume":"35","year":"2015","journal-title":"Aesthet Surg J"},{"issue":"12","key":"key\n\t\t\t\t20170407101028_CIT0059","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1111\/jdv.12408","article-title":"Double-blind, randomized non-inferiority trial of a novel botulinum toxin A processed from the strain CBFC26, compared with onabotulinumtoxin A in the treatment of glabellar lines","volume":"28","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"key\n\t\t\t\t20170407101028_CIT0060","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.biologicals.2015.06.004","article-title":"Immunogenicity assessment of biotherapeutic products: An overview of assays and their utility","volume":"43","year":"2015","journal-title":"Biologicals"},{"issue":"4","key":"key\n\t\t\t\t20170407101028_CIT0061","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1111\/j.1468-1331.2007.01683.x","article-title":"The protein load of therapeutic botulinum toxins","volume":"14","year":"2007","journal-title":"Eur J Neurol"},{"key":"key\n\t\t\t\t20170407101028_CIT0062","first-page":"227","article-title":"Botulinum toxin type A products are not interchangeable: a review of the evidence","volume":"8","year":"2014","journal-title":"Biologics"},{"issue":"1","key":"key\n\t\t\t\t20170407101028_CIT0063","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1504\/TBJ.2015.078134","article-title":"Historical aspects of botulinum toxin used clinically: Part II: overcoming resistance","volume":"3","year":"2015","journal-title":"Botulinum J"},{"issue":"5","key":"key\n\t\t\t\t20170407101028_CIT0064","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1056\/NEJM199201303260516","article-title":"Therapeutic use of type F botulinum toxin","volume":"326","year":"1992","journal-title":"N Engl J Med"},{"issue":"5","key":"key\n\t\t\t\t20170407101028_CIT0065","first-page":"516","article-title":"Botulinum toxin type B for dynamic glabellar rhytides refractory to botulinum toxin type A","volume":"29","year":"2003","journal-title":"Dermatol Surg"},{"issue":"5","key":"key\n\t\t\t\t20170407101028_CIT0066","first-page":"501","article-title":"Prospective open-label study of botulinum toxin type B (Myobloc) at doses of 2400 and 3000 U for the treatment of glabellar wrinkles","volume":"29","year":"2003","journal-title":"Dermatol Surg"},{"issue":"1 Spec No","key":"key\n\t\t\t\t20170407101028_CIT0067","first-page":"S60","article-title":"Dose-finding, safety, and tolerability study of botulinum toxin type B for the treatment of hyperfunctional glabellar lines","volume":"33","year":"2007","journal-title":"Dermatol Surg"},{"issue":"2-3","key":"key\n\t\t\t\t20170407101028_CIT0068","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/BF03033930","article-title":"Clinical use of non-A botulinum toxins: botulinum toxin type C and botulinum toxin type F","volume":"9","year":"2006","journal-title":"Neurotox Res"},{"key":"key\n\t\t\t\t20170407101028_CIT0069","author":"Galderma"},{"issue":"1 Spec No","key":"key\n\t\t\t\t20170407101028_CIT0070","first-page":"S76","article-title":"Topically applied botulinum toxin type A for the treatment of primary axillary hyperhidrosis: results of a randomized, blinded, vehicle-controlled study","volume":"33","year":"2007","journal-title":"Dermatol Surg"},{"key":"key\n\t\t\t\t20170407101028_CIT0071","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1111\/j.1524-4725.2010.01711.x","article-title":"Efficacy and safety evaluation of a novel botulinum toxin topical gel for the treatment of moderate to severe lateral canthal lines","volume":"36","year":"2010","journal-title":"Dermatol Surg"},{"key":"key\n\t\t\t\t20170407101028_CIT0072","article-title":"The different botulinum toxins from around the world currently available for clinical use","volume-title":"Botulinum Toxins in Aesthetic Clinical Practice","edition":"3"},{"key":"key\n\t\t\t\t20170407101028_CIT0073"}],"container-title":["Aesthetic Surgery Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/asj\/article-pdf\/37\/suppl_1\/S4\/11165229\/sjw284.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T04:40:47Z","timestamp":1601872847000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/asj\/article-lookup\/doi\/10.1093\/asj\/sjw284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,7]]},"references-count":73,"journal-issue":{"issue":"suppl_1","published-online":{"date-parts":[[2017,4,7]]},"published-print":{"date-parts":[[2017,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/asj\/sjw284","relation":{},"ISSN":["1090-820X","1527-330X"],"issn-type":[{"value":"1090-820X","type":"print"},{"value":"1527-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,7]]}}}